International Considerations: Evaluating the Impact of Obtaining Data from Outside the US
Time: 1:30 pm
day: Day One: Preclinical & Clinical Development
Details:
- Explore how obtaining initial data outside the US can expedite your process of moving into a later stage clinical trial in the US
- Reflect on how demonstrating safety and efficacy is crucial to de-risking scaling-up manufacturing and development, and for getting investment for other programs with similar gene editing technology
- Understand how trials outside the US may be essential to find more appropriate patient groups
